ES2089160T3 - Procedimiento para la puesta en evidencia de la aglutinacion de los eritrocitos, destinado a los analisis de compatibilidad sanguinea. - Google Patents
Procedimiento para la puesta en evidencia de la aglutinacion de los eritrocitos, destinado a los analisis de compatibilidad sanguinea.Info
- Publication number
- ES2089160T3 ES2089160T3 ES91400722T ES91400722T ES2089160T3 ES 2089160 T3 ES2089160 T3 ES 2089160T3 ES 91400722 T ES91400722 T ES 91400722T ES 91400722 T ES91400722 T ES 91400722T ES 2089160 T3 ES2089160 T3 ES 2089160T3
- Authority
- ES
- Spain
- Prior art keywords
- agglutination
- erythrocytes
- evidence
- analysis
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title abstract 2
- 210000003743 erythrocyte Anatomy 0.000 title abstract 2
- 230000004520 agglutination Effects 0.000 title 1
- 229920005654 Sephadex Polymers 0.000 abstract 1
- 230000002391 anti-complement effect Effects 0.000 abstract 1
- 108010008730 anticomplement Proteins 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 230000002949 hemolytic effect Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA INVENCION SE REFIERE A UN PROCESO DE PUESTA EN EVIDENCIA DE AGLUTINACIONES ERITROCITARIAS TRAS EL CENTRIFUGADO EN UN MEDIO GELIFICADO CONSTITUIDO DE DOS GELES DE DEXTRANO DE FINURA DE RETICULACION DIFERENTE Y QUE CONTIENE TODOS LOS REACTIVOS ESPECIFICOS DE CADA TIPO DE PRUEBA. EL PROCESO COMPRENDE LA UTILIZACION, EN EL GEL, DE UN ANTICUERPO ANTICOMPLEMENTO MONOCLONAL. LA INVENCION SE APLICA EN EL CAMPO DE LOS ANALISIS DE COMPATIBILIDADES SANGUINEAS PRE-TRANSFUSIONALES Y DE SEGUIMIENTO DE EMBARAZOS ASI COMO EN EL DIAGNOSTICO DE ENFERMEDADES Y ACCIDENTES HEMOLITICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9003873A FR2660437B1 (fr) | 1990-03-27 | 1990-03-27 | Procede de mise en evidence d'agglutination erythrocytaire destine aux analyses de comptabilites sanguines. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2089160T3 true ES2089160T3 (es) | 1996-10-01 |
Family
ID=9395144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91400722T Expired - Lifetime ES2089160T3 (es) | 1990-03-27 | 1991-03-18 | Procedimiento para la puesta en evidencia de la aglutinacion de los eritrocitos, destinado a los analisis de compatibilidad sanguinea. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0454509B1 (es) |
AT (1) | ATE139847T1 (es) |
DE (1) | DE69120463T2 (es) |
DK (1) | DK0454509T3 (es) |
ES (1) | ES2089160T3 (es) |
FR (1) | FR2660437B1 (es) |
GR (1) | GR3020960T3 (es) |
PT (1) | PT97151B (es) |
SG (1) | SG47462A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2055095C (en) * | 1990-11-09 | 2003-05-13 | Johnna B. Hawk | Column agglutination assay and device |
FR2697633B1 (fr) * | 1992-10-21 | 1995-01-20 | Pasteur Sanofi Diagnostics | Procédé d'immunodiagnostic en matrice poreuse avec particules sensibilisées et dispositif pour sa mise en Óoeuvre. |
US5552064A (en) * | 1993-02-26 | 1996-09-03 | Ortho Diagnostic Systems, Inc. | Column agglutination assay and device using biphasic centrifugation |
FR2719122B1 (fr) * | 1994-04-22 | 1996-07-12 | Scibiex Sarl | Dispositif et procédé d'analyse immunologique. |
NL9400777A (nl) * | 1994-05-10 | 1995-12-01 | Stichting Centraal Lab | Vaste-fase filtratiemethode voor antigeen- en antistofbepalingen in de bloedgroepserologie, en testkit. |
US5905028A (en) * | 1994-05-17 | 1999-05-18 | Gamma Biologicals, Inc. | Method and apparatus useful for detecting bloodgroup antigens and antibodies |
FR2732037B1 (fr) * | 1995-03-20 | 1997-05-30 | Dbv | Procede de detection de microorganismes par separation et culture sur un systeme gelifie, systeme gelifie et necessaire de dosage pour mettre en oeuvre ce procede, utilisation en microbiologie |
EP0805354A1 (en) * | 1996-04-29 | 1997-11-05 | Matthew R. Dr. Pincus | Direct detection of unexpected alloantibodies in the serum of prospective transfusion recipients using a new haemoglutination inhibition assay |
NL1003570C2 (nl) | 1996-07-11 | 1998-01-15 | Stichting Centraal Lab | Methode voor antigeen- en antistofbepaling in de bloedgroepserologie. |
ES2126521B1 (es) * | 1997-06-05 | 1999-11-16 | Transfusion De La Comunidad Va | Metodo para la deteccion de antigenos presentes en la membrana de hematies, propios o acoplados y de anticuerpos irregulares en muestras de suero. |
US20070100557A1 (en) * | 2005-10-24 | 2007-05-03 | Yi Zhang | Selection of genotyped transfusion donors by cross-matching to genotyped recipients |
EP1840572A1 (en) * | 2006-03-30 | 2007-10-03 | Stiftung Für Diagnostische Forschung | A system for the enhancement of the detection of antibodies directed against red cell antigens |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0039195B1 (en) * | 1980-04-28 | 1986-06-18 | Montefiore Hospital and Medical Center | Antibody detection process |
GB2117514B (en) * | 1982-03-29 | 1985-08-29 | East Anglian Regional Health | Polyvalent antiglobulin reagent |
FR2577321B1 (fr) * | 1985-02-08 | 1989-04-28 | Lapierre Yves | Dispositif et procede de mise en evidence d'agglutinats erythrocytaires |
JPH087215B2 (ja) * | 1987-08-24 | 1996-01-29 | シュティフツング・フュア・ディアグノスティッシュ・フォルシュンク | 抗原および/又は抗体の検出方法および検出用の試験キット |
-
1990
- 1990-03-27 FR FR9003873A patent/FR2660437B1/fr not_active Expired - Fee Related
-
1991
- 1991-03-18 AT AT91400722T patent/ATE139847T1/de not_active IP Right Cessation
- 1991-03-18 SG SG1996001863A patent/SG47462A1/en unknown
- 1991-03-18 ES ES91400722T patent/ES2089160T3/es not_active Expired - Lifetime
- 1991-03-18 DK DK91400722.4T patent/DK0454509T3/da active
- 1991-03-18 DE DE69120463T patent/DE69120463T2/de not_active Expired - Lifetime
- 1991-03-18 EP EP91400722A patent/EP0454509B1/fr not_active Expired - Lifetime
- 1991-03-26 PT PT97151A patent/PT97151B/pt not_active IP Right Cessation
-
1996
- 1996-09-05 GR GR960402315T patent/GR3020960T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
SG47462A1 (en) | 1998-04-17 |
GR3020960T3 (en) | 1996-12-31 |
EP0454509B1 (fr) | 1996-06-26 |
EP0454509A3 (fr) | 1991-11-06 |
EP0454509A2 (fr) | 1991-10-30 |
FR2660437B1 (fr) | 1993-11-19 |
ATE139847T1 (de) | 1996-07-15 |
FR2660437A1 (fr) | 1991-10-04 |
PT97151A (pt) | 1991-11-29 |
PT97151B (pt) | 1999-12-31 |
DK0454509T3 (da) | 1996-11-04 |
DE69120463T2 (de) | 1997-01-23 |
DE69120463D1 (de) | 1996-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Finegold et al. | Synthesis of immunoglobulins by human cell lines in tissue culture | |
ES2089160T3 (es) | Procedimiento para la puesta en evidencia de la aglutinacion de los eritrocitos, destinado a los analisis de compatibilidad sanguinea. | |
LV10538A (lv) | Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis | |
EP0064274B1 (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
EP0140379A3 (en) | Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies | |
Hanson | The serological relationship between human milk and blood plasma | |
Hanson et al. | Immunological characterization of chromatographically separated protein fractions from human colostrum | |
Bonhomme et al. | Mu-chain disease in an African patient | |
Louderback et al. | Clinical Evaluation of a Rapid Screening Test for Sickle Cell Trait (S [unknown]) and Sickle Cell Anemia (SS) | |
Garratty et al. | The significance of red cell bound complement components in development of standards and quality assurance for the anti‐complement components of antiglobulin sera | |
Partanen et al. | Identification of antigenic components of Toxoplasma gondii by an immunoblotting technique | |
Phillips et al. | Isoelectric spectra of different classes of anti‐erythrocyte antibodies | |
US6461825B1 (en) | Immunometric assay kit and method applicable to whole cells | |
EP0762121A1 (en) | Antigen for enzyme immunoassay and method of measuring anti-erythrocyte antibody | |
DE3780446D1 (de) | Verfahren zur feststellung von schwangerschaftsstoerungen. | |
Maidment Jr et al. | Isoelectric focusing analysis of soluble immune complexes bound to Protein A-Sepharose | |
CA1049405A (en) | Test method to determine pulmonary embolism | |
Leonard et al. | Effect of C3 inactivator on bound C3 antigen | |
SU1163864A1 (ru) | Способ определени антиэритроцитарных антител | |
Williams et al. | Reactions of Antibodies with Soluble Antigens: Methods in Immunology and Immunochemistry, Vol. 3 | |
Mischler et al. | Immunological identification of human seminal stains | |
WO1987006345A1 (en) | Colorimetric ratioing immunoassay | |
SU1175442A1 (ru) | Способ диагностики гипоксии мозга у новорожденных | |
Judd | A Bromelin Dependant ‘Pan-Agglutinin’ | |
SU1741075A1 (ru) | Способ определени специфичности иммунных комплексов с помощью эритроцитарных диагностикумов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 454509 Country of ref document: ES |
|
FG2A | Definitive protection |
Ref document number: 454509 Country of ref document: ES |